Abstract
Chickenpox and shingles can be more severe and occasionally life threatening in immunosuppressed patients. As such, some groups warrant a more detailed history, serological testing and consideration of prophylaxis following contact with the virus. Active disease may also require more aggressive treatment with antivirals. Guidance for the use of varicella zoster immunoglobulin has recently been updated by Public Health England with important implications for rheumatology patients.
| Original language | English |
|---|---|
| Pages (from-to) | 596-605 |
| Number of pages | 10 |
| Journal | Rheumatology |
| Volume | 57 |
| Issue number | 4 |
| DOIs | |
| Publication status | Published - 1 Apr 2018 |
Bibliographical note
Publisher Copyright:© The Author(s) 2018. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved.
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Acyclovir
- Antiviral
- Chickenpox
- Contact
- Immunosuppressed
- Infection
- Shingles
- VZIG
- VZV
- Vaccine
- Varicella
- Varicella zoster immunoglobulin
- Varicella zoster virus
- Zoster
Fingerprint
Dive into the research topics of 'Managing varicella zoster virus contact and infection in patients on anti-rheumatic therapy'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver